OPharmigene was publicly traded on Taiwan’s OTC stock market.
Pharmigene developed SARS-CoV-2 Antigen Rapid Tests.
LDTs Lab importer Third Generation Sequencing System.
<Genetic Testing for Common Medications in Children> was successfully developed.
Striving for the HLA-B*5801 test to be included in Taiwan’s National Health Insurance.
OEM COVID-19 Antigen Rapid Test.

HTML Snippets Powered By : XYZScripts.com
Scroll to Top